ArticleBMC cardiovascular disorders2022

Effects of Sacubitril/Valsartan on biomarkers of fibrosis and inflammation in patients with heart failure with reduced ejection fraction.

Giovanni Battista Bolla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.